Actavis Plots Another Offering To Back $66B Allergan Deal
Less than a week after raising $8.4 billion in a record-setting simultaneous offering, Actavis PLC outlined plans Monday for a senior notes offering in the Irish drugmaker's latest effort to raise...To view the full article, register now.
Already a subscriber? Click here to view full article